US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist

7.650
+0.050+0.66%

Close Oct 16 16:00 ET

645.94MMarket Cap-5795P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-21.12%225.3M

-19.11%240.65M

-6.95%263.44M

42.35%266.6M

104.28%285.6M

96.69%297.53M

70.57%283.11M

5.69%187.29M

-Cash and cash equivalents

13.07%91.5M

-64.69%65.1M

-44.20%79.93M

-39.83%37.89M

381.49%80.92M

320.14%184.35M

200.29%143.24M

-2.74%62.98M

-Short-term investments

-34.63%133.8M

55.12%175.56M

31.19%183.51M

83.98%228.71M

66.40%204.68M

5.39%113.17M

18.26%139.88M

10.55%124.31M

Other current assets

82.19%4.94M

145.14%5.24M

92.76%3.99M

18.58%3.86M

-2.83%2.71M

-24.80%2.14M

118.46%2.07M

103.44%3.25M

Total current assets

-20.14%230.24M

-17.94%245.9M

-6.23%267.43M

41.94%270.46M

102.18%288.32M

94.45%299.66M

70.84%285.19M

6.57%190.54M

Non current assets

Net PPE

-56.39%587K

-48.48%816K

-42.96%1.03M

-40.21%1.2M

-38.68%1.35M

-36.28%1.58M

72.47%1.8M

115.97%2M

-Gross PPE

-56.39%587K

-48.48%816K

-17.72%2.64M

-40.21%1.2M

-38.68%1.35M

-36.28%1.58M

43.70%3.21M

115.97%2M

-Accumulated depreciation

----

-14.76%-1.61M

----

-18.31%-1.4M

----

Other non current assets

52.78%55K

48.65%55K

51.35%56K

-25.53%35K

-43.75%36K

-48.61%37K

-60.64%37K

-72.19%47K

Total non current assets

-53.55%642K

-46.27%871K

-41.06%1.09M

-39.87%1.23M

-38.82%1.38M

-36.63%1.62M

61.49%1.84M

86.95%2.05M

Total assets

-20.30%230.88M

-18.10%246.77M

-6.45%268.52M

41.07%271.69M

99.98%289.7M

92.31%301.29M

70.78%287.03M

7.06%192.59M

Liabilities

Current liabilities

Payables

-66.17%1.87M

-36.77%1.7M

52.89%2.52M

58.79%3.33M

469.06%5.54M

60.31%2.69M

-22.62%1.65M

32.36%2.09M

-accounts payable

-66.17%1.87M

-36.77%1.7M

52.89%2.52M

58.79%3.33M

469.06%5.54M

60.31%2.69M

-22.62%1.65M

32.36%2.09M

Current accrued expenses

-9.65%5.41M

-46.25%4.07M

34.25%2.87M

63.82%3.97M

98.34%5.98M

156.28%7.57M

10.40%2.13M

-19.27%2.42M

Current debt and capital lease obligation

-61.87%249K

-34.91%427K

-8.77%603K

6.32%707K

11.43%653K

12.33%656K

--661K

--665K

-Current capital lease obligation

-61.87%249K

-34.91%427K

-8.77%603K

6.32%707K

11.43%653K

12.33%656K

--661K

--665K

Other current liabilities

14.29%320K

46.56%532K

50.27%278K

27.27%392K

87.92%280K

33.95%363K

-48.32%185K

271.08%308K

Current liabilities

-23.06%10.96M

-27.10%8.83M

41.05%11.94M

61.57%12.09M

135.57%14.24M

96.42%12.11M

24.16%8.47M

8.53%7.48M

Non current liabilities

Long term debt and capital lease obligation

----

--0

-91.03%63K

-73.80%223K

-61.40%386K

--544K

--702K

-Long term capital lease obligation

----

--0

-91.03%63K

-73.80%223K

-61.40%386K

--544K

--702K

Non current deferred liabilities

----

--0

Total non current liabilities

-4.97%1.24M

-18.42%1.22M

-25.33%1.21M

-16.73%1.18M

-18.19%1.31M

-16.50%1.49M

70.54%1.62M

67.78%1.41M

Total liabilities

-21.53%12.2M

-26.14%10.05M

30.42%13.15M

49.15%13.26M

103.39%15.55M

71.03%13.6M

29.82%10.08M

14.97%8.89M

Shareholders'equity

Share capital

16.67%7K

20.00%6K

50.00%6K

100.00%6K

66.67%5K

33.33%4K

-common stock

16.67%7K

20.00%6K

50.00%6K

100.00%6K

66.67%5K

33.33%4K

Retained earnings

-34.02%-377.74M

-34.50%-355M

-37.21%-332.63M

-37.52%-311.61M

-34.35%-281.84M

-34.77%-263.95M

-33.14%-242.42M

-35.02%-226.6M

Paid-in capital

7.20%596.85M

7.25%592.04M

13.04%588.01M

38.68%570.86M

59.88%556.76M

59.80%552.04M

51.78%520.18M

21.02%411.63M

Gains losses not affecting retained earnings

42.84%-443K

22.84%-321K

97.69%-19K

37.98%-836K

37.55%-775K

53.57%-416K

-143.20%-822K

-707.19%-1.35M

Total stockholders'equity

-20.23%218.68M

-17.71%236.72M

-7.79%255.37M

40.68%258.43M

99.79%274.15M

93.44%287.68M

72.76%276.94M

6.70%183.69M

Total equity

-20.23%218.68M

-17.71%236.72M

-7.79%255.37M

40.68%258.43M

99.79%274.15M

93.44%287.68M

72.76%276.94M

6.70%183.69M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-21.12%225.3M	-19.11%240.65M	-6.95%263.44M	-6.95%263.44M	42.35%266.6M	104.28%285.6M	96.69%297.53M	70.57%283.11M	70.57%283.11M	5.69%187.29M
-Cash and cash equivalents	13.07%91.5M	-64.69%65.1M	-44.20%79.93M	-44.20%79.93M	-39.83%37.89M	381.49%80.92M	320.14%184.35M	200.29%143.24M	200.29%143.24M	-2.74%62.98M
-Short-term investments	-34.63%133.8M	55.12%175.56M	31.19%183.51M	31.19%183.51M	83.98%228.71M	66.40%204.68M	5.39%113.17M	18.26%139.88M	18.26%139.88M	10.55%124.31M
Other current assets	82.19%4.94M	145.14%5.24M	92.76%3.99M	92.76%3.99M	18.58%3.86M	-2.83%2.71M	-24.80%2.14M	118.46%2.07M	118.46%2.07M	103.44%3.25M
Total current assets	-20.14%230.24M	-17.94%245.9M	-6.23%267.43M	-6.23%267.43M	41.94%270.46M	102.18%288.32M	94.45%299.66M	70.84%285.19M	70.84%285.19M	6.57%190.54M
Non current assets
Net PPE	-56.39%587K	-48.48%816K	-42.96%1.03M	-42.96%1.03M	-40.21%1.2M	-38.68%1.35M	-36.28%1.58M	72.47%1.8M	72.47%1.8M	115.97%2M
-Gross PPE	-56.39%587K	-48.48%816K	-17.72%2.64M	-17.72%2.64M	-40.21%1.2M	-38.68%1.35M	-36.28%1.58M	43.70%3.21M	43.70%3.21M	115.97%2M
-Accumulated depreciation	----	----	-14.76%-1.61M	-14.76%-1.61M	----	----	----	-18.31%-1.4M	-18.31%-1.4M	----
Other non current assets	52.78%55K	48.65%55K	51.35%56K	51.35%56K	-25.53%35K	-43.75%36K	-48.61%37K	-60.64%37K	-60.64%37K	-72.19%47K
Total non current assets	-53.55%642K	-46.27%871K	-41.06%1.09M	-41.06%1.09M	-39.87%1.23M	-38.82%1.38M	-36.63%1.62M	61.49%1.84M	61.49%1.84M	86.95%2.05M
Total assets	-20.30%230.88M	-18.10%246.77M	-6.45%268.52M	-6.45%268.52M	41.07%271.69M	99.98%289.7M	92.31%301.29M	70.78%287.03M	70.78%287.03M	7.06%192.59M
Liabilities
Current liabilities
Payables	-66.17%1.87M	-36.77%1.7M	52.89%2.52M	52.89%2.52M	58.79%3.33M	469.06%5.54M	60.31%2.69M	-22.62%1.65M	-22.62%1.65M	32.36%2.09M
-accounts payable	-66.17%1.87M	-36.77%1.7M	52.89%2.52M	52.89%2.52M	58.79%3.33M	469.06%5.54M	60.31%2.69M	-22.62%1.65M	-22.62%1.65M	32.36%2.09M
Current accrued expenses	-9.65%5.41M	-46.25%4.07M	34.25%2.87M	34.25%2.87M	63.82%3.97M	98.34%5.98M	156.28%7.57M	10.40%2.13M	10.40%2.13M	-19.27%2.42M
Current debt and capital lease obligation	-61.87%249K	-34.91%427K	-8.77%603K	-8.77%603K	6.32%707K	11.43%653K	12.33%656K	--661K	--661K	--665K
-Current capital lease obligation	-61.87%249K	-34.91%427K	-8.77%603K	-8.77%603K	6.32%707K	11.43%653K	12.33%656K	--661K	--661K	--665K
Other current liabilities	14.29%320K	46.56%532K	50.27%278K	50.27%278K	27.27%392K	87.92%280K	33.95%363K	-48.32%185K	-48.32%185K	271.08%308K
Current liabilities	-23.06%10.96M	-27.10%8.83M	41.05%11.94M	41.05%11.94M	61.57%12.09M	135.57%14.24M	96.42%12.11M	24.16%8.47M	24.16%8.47M	8.53%7.48M
Non current liabilities
Long term debt and capital lease obligation	----	----	--0	--0	-91.03%63K	-73.80%223K	-61.40%386K	--544K	--544K	--702K
-Long term capital lease obligation	----	----	--0	--0	-91.03%63K	-73.80%223K	-61.40%386K	--544K	--544K	--702K
Non current deferred liabilities	----	----	----	----	----	----	----	----	----	--0
Total non current liabilities	-4.97%1.24M	-18.42%1.22M	-25.33%1.21M	-25.33%1.21M	-16.73%1.18M	-18.19%1.31M	-16.50%1.49M	70.54%1.62M	70.54%1.62M	67.78%1.41M
Total liabilities	-21.53%12.2M	-26.14%10.05M	30.42%13.15M	30.42%13.15M	49.15%13.26M	103.39%15.55M	71.03%13.6M	29.82%10.08M	29.82%10.08M	14.97%8.89M
Shareholders'equity
Share capital	16.67%7K	20.00%6K	20.00%6K	20.00%6K	50.00%6K	100.00%6K	66.67%5K	66.67%5K	66.67%5K	33.33%4K
-common stock	16.67%7K	20.00%6K	20.00%6K	20.00%6K	50.00%6K	100.00%6K	66.67%5K	66.67%5K	66.67%5K	33.33%4K
Retained earnings	-34.02%-377.74M	-34.50%-355M	-37.21%-332.63M	-37.21%-332.63M	-37.52%-311.61M	-34.35%-281.84M	-34.77%-263.95M	-33.14%-242.42M	-33.14%-242.42M	-35.02%-226.6M
Paid-in capital	7.20%596.85M	7.25%592.04M	13.04%588.01M	13.04%588.01M	38.68%570.86M	59.88%556.76M	59.80%552.04M	51.78%520.18M	51.78%520.18M	21.02%411.63M
Gains losses not affecting retained earnings	42.84%-443K	22.84%-321K	97.69%-19K	97.69%-19K	37.98%-836K	37.55%-775K	53.57%-416K	-143.20%-822K	-143.20%-822K	-707.19%-1.35M
Total stockholders'equity	-20.23%218.68M	-17.71%236.72M	-7.79%255.37M	-7.79%255.37M	40.68%258.43M	99.79%274.15M	93.44%287.68M	72.76%276.94M	72.76%276.94M	6.70%183.69M
Total equity	-20.23%218.68M	-17.71%236.72M	-7.79%255.37M	-7.79%255.37M	40.68%258.43M	99.79%274.15M	93.44%287.68M	72.76%276.94M	72.76%276.94M	6.70%183.69M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data